First North American experience of propiverine use in children with overactive bladder
First North American experience of propiverine use in children with overactive bladder
About this item
Full title
Author / Creator
Publisher
Canada: Canadian Urological Association
Journal title
Language
English
Formats
Publication information
Publisher
Canada: Canadian Urological Association
Subjects
More information
Scope and Contents
Contents
In 2017, propiverine was approved in Canada for overactive bladder (OAB) in adults and children. There is, however, scarce data on its efficacy and tolerability in the pediatric population. Our primary objective was to assess the efficacy and tolerability of propiverine as a treatment for pediatric OAB. Our secondary objective was to compare propiv...
Alternative Titles
Full title
First North American experience of propiverine use in children with overactive bladder
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9565064
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9565064
Other Identifiers
ISSN
1911-6470
E-ISSN
1920-1214
DOI
10.5489/cuaj.7811
